05/08/2025
6:15 AM | Rapport Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
6:30 AM | Rapport Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2025
5:07 AM | Rapport Therapeutics (Filer)
| Form DEF 14A | |
04/24/2025
5:08 AM | Rapport Therapeutics (Filer)
| Form DEFA14A | |
04/24/2025
5:10 AM | Rapport Therapeutics (Filer)
| Form ARS | |
04/16/2025
4:00 PM | Bredt David (Reporting)
Rapport Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
4:00 PM | Bredt David (Reporting)
Rapport Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
3:20 PM | Bredt David (Reporting)
Rapport Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2025
4:13 PM | Ignelzi Troy A. (Reporting)
Rapport Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
6:45 AM | Rapport Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/11/2025
6:30 AM | Rapport Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for RAPP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/11/2025
6:15 AM | Rapport Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2025
6:14 AM | Rapport Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
3:15 PM | Rapport Therapeutics (Subject)
Third Rock Ventures V, L.P. (Filed by)
| Form SCHEDULE 13G | |
02/04/2025
4:30 PM | Gault Cheryl (Reporting)
Rapport Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:30 PM | Ceesay Abraham (Reporting)
Rapport Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:30 PM | Bredt David (Reporting)
Rapport Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:30 PM | Rapport Therapeutics (Issuer)
Yeleswaram Krishnaswamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:30 PM | Ignelzi Troy A. (Reporting)
Rapport Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
5:30 AM | Rapport Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
2:11 PM | Cormorant Asset Management, LP (Filed by)
Rapport Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
11:26 AM | Capital International Investors (Filed by)
Rapport Therapeutics (Subject)
| Form SC 13G | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Rapport Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024
5:59 PM | Rapport Therapeutics (Issuer)
Silva Paul M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
6:00 PM | PEREZ ROBERT J (Reporting)
Rapport Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
6:00 PM | Rapport Therapeutics (Issuer)
Young Wendy B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
5:35 PM | Rapport Therapeutics (Issuer)
Silva Paul M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/07/2024
5:45 PM | PEREZ ROBERT J (Reporting)
Rapport Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/07/2024
5:47 PM | Rapport Therapeutics (Issuer)
Sanchez Ramiro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
5:27 PM | Rapport Therapeutics (Issuer)
Young Wendy B. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/07/2024
5:31 PM | Rapport Therapeutics (Issuer)
Sanchez Ramiro (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/07/2024
6:30 AM | Rapport Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:15 AM | Rapport Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
4:23 PM | JOHNSON & JOHNSON (Filed by)
Rapport Therapeutics (Subject)
| Form SC 13G | |
08/08/2024
6:40 AM | Rapport Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
6:20 AM | Rapport Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
9:10 AM | FMR LLC (Filed by)
Rapport Therapeutics (Subject)
| Form SC 13G | |
07/03/2024
7:04 PM | HEALY JAMES (Reporting)
Rapport Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
8:00 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Rapport Therapeutics (Subject)
| Form SC 13G/A | |
06/21/2024
3:52 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Rapport Therapeutics (Subject)
| Form SC 13G | |
